Chemed/$CHE
1D1W1MYTD1Y5YMAX
About Chemed
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
- Ticker
- $CHE
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 15,811
- Headquarters
- Cincinnati, United States
- Website
- www.chemed.com
Chemed Metrics
BasicAdvanced
$7B
27.15
$19.91
0.51
$2.40
0.44%
Price and volume
Market cap
$7B
Beta
0.51
52-week high
$557.00
52-week low
$365.21
Average daily volume
165K
Dividend rate
$2.40
Financial strength
Current ratio
0.911
Quick ratio
0.716
Long term debt to equity
30.525
Total debt to equity
35.495
Dividend payout ratio (TTM)
12.07%
Interest coverage (TTM)
108.20%
Profitability
EBITDA (TTM)
416.918
Gross margin (TTM)
33.11%
Net profit margin (TTM)
10.60%
Operating margin (TTM)
13.67%
Effective tax rate (TTM)
25.51%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
13.45%
Return on equity (TTM)
27.11%
Valuation
Price to earnings (TTM)
27.154
Price to revenue (TTM)
2.876
Price to book
8.47
Price to tangible book (TTM)
133.98
Price to free cash flow (TTM)
23.063
Free cash flow yield (TTM)
4.34%
Free cash flow per share (TTM)
23.439
Dividend yield (TTM)
0.44%
Forward dividend yield
0.44%
Growth
Revenue change (TTM)
3.31%
Earnings per share change (TTM)
2.22%
3-year revenue growth (CAGR)
5.87%
10-year revenue growth (CAGR)
5.18%
3-year earnings per share growth (CAGR)
9.91%
10-year earnings per share growth (CAGR)
12.18%
3-year dividend per share growth (CAGR)
16.45%
10-year dividend per share growth (CAGR)
9.60%
What the Analysts think about Chemed
Analyst ratings (Buy, Hold, Sell) for Chemed stock.
Chemed Financial Performance
Revenues and expenses
Chemed Earnings Performance
Company profitability
Chemed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.